A federal judge in Kansas has appointed Dallas lawyer Warren T. Burns and two other attorneys to lead a nationwide class action against Mylan NV and other defendants over pricing practices involving the EpiPen allergy treatment. Burns is a partner at Burns Charest, a litigation boutique with offices in Dallas and New Orleans.
Mylan, the US distributor of EpiPens, sparked outrage after raising the price of its life-saving product from $100 in 2008 to more than $600 by 2016. Congress and federal agencies have since opened investigations into EpiPen pricing.
“This suit is about taking a stand for Americans who suffer life-threatening conditions,” Burns said. “We intend to send a message to Mylan and other companies that preying on the weak and the sick is no longer an accepted method of padding their bottom line.”
Full Content: Yahoo
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
